AIMS: Chronic heart failure (CHF) due to left ventricular systolic dysfunction is associated with poor quality of life (QoL). This study aimed to assess factors affecting health-related QoL in CHF patients and their carers and the impact of QoL on clinical outcomes. METHODS AND RESULTS: Demographic, social, and clinical data were collected for consecutive CHF patients in an academic hospital setting. All patients (n = 179) and informal carers (n = 131) completed a generic QoL questionnaire (EQ-5D) and patients also completed a CHF-specific QoL questionnaire (Minnesota Living with Heart Failure Questionnaire, MLHFQ). Patients were then followed up for 3 years to assess subsequent hospitalizations and mortality. Minnesota Living with Heart Failure Questionnaire score was independently predicted by NYHA class, socioeconomic deprivation and lack of an informal carer. Severity of heart failure, anaemia, and cancer co-morbidity in CHF patients were associated with poor QoL in carers. Chronic heart failure patients with poor baseline QoL (MLHFQ > median) were at increased risk of hospital admissions [hazard ratios (HR) 7.3, P < 0.001] and death (HR 1.5, P = 0.09). Mortality was also independently associated with repeat hospitalization (HR 6.0, P < 0.001) and lack of beta-blocker therapy (HR 1.8, P = 0.03). CONCLUSION: Severe heart failure, poor socioeconomic status and lack of social support results in poor QoL in CHF patients which in turn leads to an increased risk of hospital admissions and death. Quality of life in carers is lower in female carers, those with socioeconomic deprivation and those caring for patients with higher NYHA class or having a cancer. Quality of life assessment may complement clinical prognostic markers to identify CHF patients at high risk of adverse events.
AIMS: Chronic heart failure (CHF) due to left ventricular systolic dysfunction is associated with poor quality of life (QoL). This study aimed to assess factors affecting health-related QoL in CHFpatients and their carers and the impact of QoL on clinical outcomes. METHODS AND RESULTS: Demographic, social, and clinical data were collected for consecutive CHFpatients in an academic hospital setting. All patients (n = 179) and informal carers (n = 131) completed a generic QoL questionnaire (EQ-5D) and patients also completed a CHF-specific QoL questionnaire (Minnesota Living with Heart Failure Questionnaire, MLHFQ). Patients were then followed up for 3 years to assess subsequent hospitalizations and mortality. Minnesota Living with Heart Failure Questionnaire score was independently predicted by NYHA class, socioeconomic deprivation and lack of an informal carer. Severity of heart failure, anaemia, and cancer co-morbidity in CHFpatients were associated with poor QoL in carers. Chronic heart failurepatients with poor baseline QoL (MLHFQ > median) were at increased risk of hospital admissions [hazard ratios (HR) 7.3, P < 0.001] and death (HR 1.5, P = 0.09). Mortality was also independently associated with repeat hospitalization (HR 6.0, P < 0.001) and lack of beta-blocker therapy (HR 1.8, P = 0.03). CONCLUSION: Severe heart failure, poor socioeconomic status and lack of social support results in poor QoL in CHFpatients which in turn leads to an increased risk of hospital admissions and death. Quality of life in carers is lower in female carers, those with socioeconomic deprivation and those caring for patients with higher NYHA class or having a cancer. Quality of life assessment may complement clinical prognostic markers to identify CHFpatients at high risk of adverse events.
Authors: Razi Khan; David Massel; John Stirrat; David Scholl; Gerald Wisenberg; Terry Thompson; Maria Drangova; James A White Journal: Int J Cardiovasc Imaging Date: 2012-08-09 Impact factor: 2.357
Authors: Thomas Nesbitt; Sahar Doctorvaladan; Jeffrey A Southard; Satinder Singh; Anne Fekete; Kate Marie; Debra K Moser; Michelle M Pelter; Susan Robinson; Machelle D Wilson; Lawton Cooper; Kathleen Dracup Journal: Circ Heart Fail Date: 2014-08-21 Impact factor: 8.790
Authors: Himali Weerahandi; Nathan Goldstein; Laura P Gelfman; Ulrich Jorde; James N Kirkpatrick; Judith Marble; Yoshifumi Naka; Sean Pinney; Mark S Slaughter; Emilia Bagiella; Deborah D Ascheim Journal: J Pain Symptom Manage Date: 2016-07-09 Impact factor: 3.612
Authors: Margaret Glogowska; Rosemary Simmonds; Sarah McLachlan; Helen Cramer; Tom Sanders; Rachel Johnson; Umesh T Kadam; Daniel S Lasserson; Sarah Purdy Journal: Ann Fam Med Date: 2015-09 Impact factor: 5.166
Authors: Olatz Garin; Michael Herdman; Gemma Vilagut; Montse Ferrer; Aida Ribera; Luis Rajmil; José M Valderas; Francis Guillemin; Dennis Revicki; Jordi Alonso Journal: Heart Fail Rev Date: 2014-05 Impact factor: 4.214
Authors: Marion Schowalter; Götz Gelbrich; Stefan Störk; Jan-Philip Langguth; Caroline Morbach; Georg Ertl; Hermann Faller; Christiane E Angermann Journal: Clin Res Cardiol Date: 2012-12-21 Impact factor: 5.460
Authors: Mariëlle Amj Daamen; Jan P H Hamers; Anton P M Gorgels; Hans-Peter Brunner-la Rocca; Frans E S Tan; Marja P van Dieijen-Visser; Jos M G A Schols Journal: BMC Geriatr Date: 2012-06-11 Impact factor: 3.921